SEC Filing | Alamar Biosciences, Inc.

View:

SEC FORM 4SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Qiming Corporate GP VI, Ltd.

(Last)

(First)

(Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE

GRAND CAYMAN

KY1-1104

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]
Foreign Trading Symbol

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/19/2026		S		1,320	D	$26.34⁽¹⁾	180,808	I	See footnote⁽²⁾
Common Stock	10/19/2026		S		49,044	D	$26.34⁽¹⁾	6,719,561	I	See footnote⁽³⁾
Common Stock	10/19/2026		S		11,443	D	$26.34⁽¹⁾	1,567,881	I	See footnote⁽⁴⁾
Common Stock	10/19/2026		S		13,701	D	$26.34⁽¹⁾	1,877,116	I	See footnote⁽⁵⁾
Common Stock	10/20/2026		S		200	D	$26.63⁽⁶⁾	180,608	I	See footnote⁽²⁾
Common Stock	10/20/2026		S		1,947	D	$27.93⁽⁷⁾	178,661	I	See footnote⁽²⁾
Common Stock	10/20/2026		S		335	D	$28.44⁽⁸⁾	178,326	I	See footnote⁽²⁾
Common Stock	10/20/2026		S		7,415	D	$26.63⁽⁶⁾	6,712,146	I	See footnote⁽³⁾
Common Stock	10/20/2026		S		72,373	D	$27.93⁽⁷⁾	6,639,773	I	See footnote⁽³⁾
Common Stock	10/20/2026		S		12,447	D	$28.44⁽⁸⁾	6,627,326	I	See footnote⁽³⁾
Common Stock	10/20/2026		S		1,730	D	$26.63⁽⁶⁾	1,566,151	I	See footnote⁽⁴⁾
Common Stock	10/20/2026		S		16,887	D	$27.93⁽⁷⁾	1,549,264	I	See footnote⁽⁴⁾
Common Stock	10/20/2026		S		2,904	D	$28.44⁽⁸⁾	1,546,360	I	See footnote⁽⁴⁾
Common Stock	10/20/2026		S		2,072	D	$26.63⁽⁶⁾	1,875,044	I	See footnote⁽⁵⁾
Common Stock	10/20/2026		S		20,217	D	$27.93⁽⁷⁾	1,854,827	I	See footnote⁽⁵⁾
Common Stock	10/20/2026		S		3,477	D	$28.44⁽⁸⁾	1,851,350	I	See footnote⁽⁵⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

Qiming Corporate GP VI, Ltd.

(Last)

(First)

(Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE

GRAND CAYMAN

KY1-1104

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

1. Name and Address of Reporting Person^*

Qiming Managing Directors Fund VI, L.P.

(Last)

(First)

(Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE

GRAND CAYMAN

KY1-1104

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

1. Name and Address of Reporting Person^*

Qiming Venture Partners VI, L.P.

(Last)

(First)

(Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE

GRAND CAYMAN

KY1-1104

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

1. Name and Address of Reporting Person^*

Qiming GP VIII, LLC

(Last)

(First)

(Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE

GRAND CAYMAN

KY1-1104

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

1. Name and Address of Reporting Person^*

Qiming Venture Partners VIII Investments, LLC

(Last)

(First)

(Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE

GRAND CAYMAN

KY1-1104

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

1. Name and Address of Reporting Person^*

Qiming GP VIII-HC, LLC

(Last)

(First)

(Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE

GRAND CAYMAN

KY1-1104

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

1. Name and Address of Reporting Person^*

Qiming Venture Partners VIII-HC, L.P.

(Last)

(First)

(Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE

GRAND CAYMAN

KY1-1104

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2 to $26.52, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) through (4) to this Form 4.

2. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

3. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

4. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

5. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.96, inclusive.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.28 to $28.27, inclusive.

8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $28.73, inclusive.

	Qiming Corporate GP VI, Ltd By: /s/ Ho Man LAM/Authorized Signatory	10/21/2026
	Qiming Managing Directors Fund VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory	10/21/2026
	Qiming Venture Partners VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory	10/21/2026
	Qiming GP VIII, LLC By: /s/ Ho Man LAM/Authorized Signatory	10/21/2026
	Qiming Venture Partners VIII Investments, LLC By: /s/ Ho Man LAM/Manager	10/21/2026
	Qiming GP VIII-HC, LLC By: /s/ Ho Man LAM/Authorized Signatory	10/21/2026
	Qiming Venture Partners VIII-HC, L.P. By: /s/ Ho Man LAM/Authorized Signatory	10/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.